Ttrap is a novel component of the non-canonical TRAF6-TAK1 TGF-β signaling pathway

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Várady, György ^a   Sarkadi, Balázs ^a   Fátyol, Károly ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TTRAP; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; UNCLASSIFIED DRUG; MAP KINASE KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; UBIQUITINATION; ANIMAL; CELL STRAIN HEK293; CHEMISTRY; DRUG EFFECT; ENZYME ACTIVATION; METABOLISM; MOUSE; PROTEIN STABILITY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; ENZYME ACTIVATION; HEK293 CELLS; HUMANS; MAP KINASE KINASE KINASES; MICE; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS; UBIQUITINATION;

EID: 84856203450     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025548     Document Type: Article

References (61)

1. Bierie B, Moses HL, (2006) Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 6: 506-520.
2. Massagué J, (2008) TGFβ in Cancer. Cell 134: 215-230.
3. Pardali K, Moustakas A, (2007) Actions of TGF-β as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta 1775: 21-62.
4. Feng XH, Derynck R, (2005) Specificity and versatility in TGF-beta signaling through Smads. Annu Rev Cell Dev Biol 21: 659-693.
5. Mas sagué J, Seoane J, Wotton D, (2005) Smad transcription factors. Genes Dev 19: 2783-2810.
6. Derynck R, Zhang YE, (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425: 577-584.
7. Moustakas A, Heldin CH, (2005) Non-Smad TGF-β signals. J Cell Sci 118: 3573-3584.
8. Zhang YE, (2009) Non-Smad pathways in TGF-β signaling. Cell Res 19: 128-139.
9. Hanafusa H, Ninomiya-Tsuji J, Masuyama N, Nishita M, Fujisawa J, et al. (1999) Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-β-induced gene expression. J Biol Chem 274: 27161-27167.
10. Sano Y, Harada J, Tashiro S, Gotoh-Mandeville R, Maekawa T, et al. (1999) ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-β signaling. J Biol Chem 274: 8949-8957.
11. Yu L, Hébert MC, Zhang YE, (2002) TGF-β receptor-activated p38 MAP kinase mediates Smad-independent TGF-β responses. EMBO J 21: 3749-3759.
12. Edlund S, Bu S, Schuster N, Aspenström P, Heuchel R, et al. (2003) Transforming growth factor-β1 (TGF-β)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-β-activated kinase 1 and mitogen-activated protein kinase kinase 3. Mol Biol Cell 14: 529-544.
13. Galliher AJ, Schiemann WP, (2006) Beta3 integrin and Src facilitate transforming growth factor-β mediated induction of epithelial-mesenchymal transition in mammary epithelial cells. Breast Cancer Res 8: R42.
14. Galliher AJ, Schiemann WP, (2007) Src phosphorylates Tyr284 in TGF-β type II receptor and regulates TGF-β stimulation of p38 MAPK during breast cancer cell proliferation and invasion. Cancer Res 67: 3752-3758.
15. Galliher-Beckley AJ, Schiemann WP, (2008) Grb2 binding to Tyr284 in TβR-II is essential for mammary tumor growth and metastasis stimulated by TGF-β. Carcinogenesis 29: 244-251.
16. Neil JR, Tian M, Schiemann WP, (2009) X-linked inhibitor of apoptosis protein and its E3 ligase activity promote transforming growth factor-β-mediated nuclear factor-κB activation during breast cancer progression. J Biol Chem 284: 21209-21217.
17. Neil JR, Schiemann WP, (2008) Altered TAB1:IκB kinase interaction promotes transforming growth factor β-mediated nuclear factor-κB activation during breast cancer progression. Cancer Res 68: 1462-1470.
18. Parvani JG, Taylor MA, Schiemann WP, (2011) Noncanonical TGF-β Signaling During Mammary Tumorigenesis. J Mammary Gland Biol Neoplasia In press.
19. Wendt MK, Smith JA, Schiemann WP, (2009) p130Cas is required for mammary tumor growth and transforming growth factor-β-mediated metastasis through regulation of Smad2/3 activity. J Biol Chem 284: 34145-34156.
20. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, et al. (1995) Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270: 2008-2011.
21. Shim JH, Xiao C, Paschal AE, Bailey ST, Rao P, et al. (2005) TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways invivo. Genes Dev 19: 2668-2681.
22. Jadrich JL, O'Connor MB, Coucouvanis E, (2006) The TGF β activated kinase TAK1 regulates vascular development in vivo. Development 133: 1529-1541.
23. Yamashita M, Fátyol K, Jin C, Wang X, Liu Z, et al. (2008) TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-β. Mol Cell 31: 918-924.
24. Sorrentino A, Thakur N, Grimsby S, Marcusson A, von Bulow V, et al. (2008) The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol 10: 1199-1207.
25. Delaney JR, Mlodzik M, (2006) TGF-beta activated kinase-1: new insights into the diverse roles of TAK1 in development and immunity. Cell Cycle 5: 2852-2855.
26. Landström M, (2010) The TAK1-TRAF6 signalling pathway. Int J Biochem Cell Biol 42: 585-589.
27. Pype S, Declercq W, Ibrahimi A, Michiels C, Van Rietschoten JG, et al. (2000) TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation. J Biol Chem 275: 18586-18593.
28. Pei H, Yordy JS, Leng Q, Zhao Q, Watson DK, et al. (2003) EAPII interacts with ETS1and modulates its transcriptional function. Oncogene 22: 2699-2709.
29. Xu GL, Pan YK, Wang BY, Huang L, Tian L, et al. (2008) TTRAP is a novel PML nuclear bodies-associated protein. Biochem Biophys Res Commun 375: 395-398.
30. Cortes Ledesma F, El Khamisy SF, Zuma MC, Osborn K, Caldecott KW, (2009) A human 5′-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage. Nature 461: 674-678.
31. Zeng Z, Cortés-Ledesma F, El Khamisy SF, Caldecott KW, (2011) TDP2/TTRAP is the major 5′-tyrosyl DNA phosphodiesterase activity in vertebrate cells and is critical for cellular resistance to topoisomerase II-induced DNA damage. J Biol Chem 286: 403-409.
32. Esguerra CV, Nelles L, Vermeire L, Ibrahimi A, Crawford AD, et al. (2007) Ttrap is an essential modulator of Smad3-dependent Nodal signaling during zebrafish gastrulation and left-right axis determination. Development 134: 4381-4393.
33. Fátyol K, Szalay AA, (2001) The p14ARF tumor suppressor protein facilitates nucleolar sequestration of hypoxia-inducible factor-1alpha (HIF-1alpha) and inhibits HIF-1-mediated transcription. J Biol Chem 276: 28421-28429.
34. Graycar JL, Miller DA, Arrick BA, Lyons RM, Moses HL, et al. (1989) Human transforming growth factor-beta 3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-beta 1 and-beta 2. Mol Endocrinol 3: 1977-1986.
35. Morgenstern JP, Land H, (1990) Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 18: 3587-3596.
36. Rodrigues-Lima F, Josephs M, Katan M, Cassinat B, (2001) Sequence analysis identifies TTRAP, a protein that associates with CD40 and TNF receptor-associated factors, as a member of a superfamily of divalent cation-dependent phosphodiesterases. Biochem Biophys Res Commun 285: 1274-1279.
37. Kishimoto K, Matsumoto K, Ninomiya-Tsuji J, (2000) TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop. J Biol Chem 275: 7359-7364.
38. Singhirunnusorn P, Suzuki S, Kawasaki N, Saiki I, Sakurai H, (2005) Critical roles of threonine 187 phosphorylation in cellular stress-induced rapid and transient activation of transforming growth factor-β-activated kinase 1 (TAK1) in a signaling complex containing TAK1-binding protein TAB1 and TAB2. J Biol Chem 280: 7359-7368.
39. Ninomiya-Tsuji J, Kajino T, Ono K, Ohtomo T, Matsumoto M, et al. (2003) A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J Biol Chem 278: 18485-18490.
40. Ishitani T, Takaesu G, Ninomiya-Tsuji J, Shibuya H, Gaynor RB, et al. (2003) Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling. EMBO J 22: 6277-6288.
41. Kanayama A, Seth RB, Sun L, Ea CK, Hong M, et al. (2004) TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol Cell 15: 535-548.
42. Shibuya H, Yamaguchi K, Shirakabe K, Tonegawa A, Gotoh Y, et al. (1996) TAB1: an activator of the TAK1 MAPKKK in TGF-β signal transduction. Science 272: 1179-1182.
43. Takaesu G, Kishida S, Hiyama A, Yamaguchi K, Shibuya H, et al. (2000) TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol Cell 5: 649-658.
44. Karin M, Gallagher E, (2009) TNFR signaling: ubiquitin-conjugated TRAFfic signals control stop-and-go for MAPK signaling complexes. Immunol Rev 228: 225-240.
45. Davies CC, Mak TW, Young LS, Eliopoulos AG, (2005) TRAF6 is required for TRAF2-dependent CD40 signal transduction in nonhemopoietic cells. Mol Cell Biol 25: 9806-9819.
46. Deng L, Wang C, Spencer E, Yang L, Braun A, et al. (2000) Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103: 351-361.
47. Adhikari A, Xu M, Chen ZJ, (2007) Ubiquitin-mediated activation of TAK1 and IKK. Oncogene 26: 3214-3226.
48. Chen ZJ, Sun LJ, (2009) Nonproteolytic functions of ubiquitin in cell signaling. Mol Cell 33: 275-286.
49. Kim SI, Kwak JH, Na HJ, Kim JK, Ding Y, et al. (2009) Transforming growth factor-β (TGF-β1) activates TAK1 via TAB1-mediated autophosphorylation, independent of TGF-β receptor kinase activity in mesangial cells. J Biol Chem 284: 22285-22296.
50. Watkins SJ, Jonker L, Arthur HM, (2006) A direct interaction between TGFβ activated kinase 1 and the TGFβ type II receptor: implications for TGFβ signalling and cardiac hypertrophy. Cardiovasc Res 69: 432-439.
51. Arsura M, FitzGerald MJ, Fausto N, Sonenshein GE, (1997) Nuclear factor-kappaB/Rel blocks transforming growth factor beta1-induced apoptosis of murine hepatocyte cell lines. Cell Growth Differ 8: 1049-1059.
52. Zucchelli S, Vilotti S, Calligaris R, Lavina ZS, Biagioli M, et al. (2009) Aggresome-forming TTRAP mediates pro-apoptotic properties of Parkinson's disease-associated DJ-1 missense mutations. Cell Death Differ 16: 428-438.
53. Takekawa M, Tatebayashi K, Itoh F, Adachi M, Imai K, et al. (2002) Smad-dependent GADD45β expression mediates delayed activation of p38 MAP kinase by TGF-β. EMBO J 21: 6473-6482.
54. Yoo J, Ghiassi M, Jirmanova L, Balliet AG, Hoffman B, et al. (2003) Transforming growth factor-β-induced apoptosis is mediated by Smad-dependent expression of GADD45β through p38 activation. J Biol Chem 278: 43001-43007.
55. Ramjaun AR, Tomlinson S, Eddaoudi A, Downward J, (2007) Upregulation of two BH3-only proteins, Bmf and Bim, during TGF β-induced apoptosis. Oncogene 26: 970-981.
56. Li C, Fan S, Owonikoko TK, Khuri FR, Sun SY, et al. (2011) Oncogenic role of EAPII in lung cancer development and its activation of the MAPK-ERK pathway. Oncogene In press.
57. Arsura M, Panta GR, Bilyeu JD, Cavin LG, Sovak MA, et al. (2003) Transient activation of NF-κB through a TAK1/IKK kinase pathway by TGF-β1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation. Oncogene 22: 412-425.
58. Arsura M, Wu M, Sonenshein GE, (1996) TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha. Immunity 5: 31-40.
59. Sovak MA, Arsura M, Zanieski G, Kavanagh KT, Sonenshein GE, (1999) The inhibitory effects of transforming growth factor beta1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-kappaB/Rel expression. Cell Growth Differ 10: 537-544.
60. Resch U, Schichl YM, Winsauer G, Gudi R, Prasad K, et al. (2009) Siva1 is a XIAP-interacting protein that balances NFkappaB and JNK signalling to promote apoptosis. J Cell Sci 122: 2651-2661.
61. Lee HY, Youn SW, Kim JY, Park KW, Hwang CI, et al. (2008) FOXO3a turns the tumor necrosis factor receptor signaling towards apoptosis through reciprocal regulation of c-Jun N-terminal kinase and NF-kappaB. Arterioscler Thromb Vasc Biol 28: 112-120.